Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 4:27 pm Purchase |
2023-02-07 | 13D | Avalo Therapeutics, Inc. AVTX |
ARMISTICE CAPITAL LLC | 19,928 35.400% |
1,876 (+10.39%) |
Filing History |
| 2022-09-23 1:40 pm Purchase |
2022-09-23 | 13G | Freshpet, Inc. FRPT |
ARMISTICE CAPITAL LLC | 2,650,000 5.500% |
2,650,000 (New Position) |
Filing History |
| 2022-08-11 4:09 pm Sale |
2022-08-08 | 13D | Avalo Therapeutics, Inc. AVTX |
ARMISTICE CAPITAL LLC | 18,052 44.400% |
-0 (-0.00%) |
Filing History |
| 2022-06-21 06:08 am Unchanged |
2022-06-21 | 13G | Tenax Therapeutics, Inc. TENX |
ARMISTICE CAPITAL LLC | 1,608 9.990% |
0 (Unchanged) |
Filing History |
| 2022-06-17 5:16 pm Purchase |
2022-06-10 | 13D | Tenax Therapeutics, Inc. TENX |
ARMISTICE CAPITAL LLC | 1,608 9.990% |
0 (+0.02%) |
Filing History |
| 2022-05-20 4:52 pm Unchanged |
2022-05-17 | 13D | Tenax Therapeutics, Inc. TENX |
ARMISTICE CAPITAL LLC | 1,608 9.990% |
0 (Unchanged) |
Filing History |
| 2022-03-15 5:16 pm Purchase |
2022-03-14 | 13D | Avalo Therapeutics, Inc. AVTX |
ARMISTICE CAPITAL LLC | 18,052 44.500% |
408 (+2.31%) |
Filing History |
| 2022-02-14 9:56 pm Sale |
2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA |
ARMISTICE CAPITAL LLC | 0 0.000% |
-5,399,277 (Position Closed) |
Filing History |
| 2022-02-14 9:55 pm Sale |
2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS |
ARMISTICE CAPITAL LLC | 0 0.000% |
-2,742,000 (Position Closed) |
Filing History |
| 2022-02-14 9:54 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
ARMISTICE CAPITAL LLC | 0 0.000% |
-3,392,000 (Position Closed) |
Filing History |
| 2022-02-14 9:37 pm Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
ARMISTICE CAPITAL LLC | 800,000 5.100% |
800,000 (New Position) |
Filing History |
| 2022-02-14 7:10 pm Sale |
2021-12-31 | 13G | BIOLASE, Inc. BIOL |
ARMISTICE CAPITAL LLC | 0 0.000% |
-2,872 (Position Closed) |
Filing History |
| 2022-02-14 7:03 pm Purchase |
2021-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
ARMISTICE CAPITAL LLC | 4,136,000 7.800% |
1,016,000 (+32.56%) |
Filing History |
| 2022-02-14 7:01 pm Sale |
2021-12-31 | 13G | Lantheus Holdings, Inc. LNTH |
ARMISTICE CAPITAL LLC | 0 0.000% |
-5,200,000 (Position Closed) |
Filing History |
| 2022-02-14 6:48 pm Purchase |
2021-12-31 | 13G | XTI Aerospace, Inc. XTIA |
ARMISTICE CAPITAL LLC | 7 9.990% |
7 (New Position) |
Filing History |
| 2022-02-14 6:46 pm Purchase |
2021-12-31 | 13G | Conformis, Inc. CFMS |
ARMISTICE CAPITAL LLC | 480,000 6.100% |
98,466 (+25.81%) |
Filing History |
| 2022-02-14 6:44 pm Sale |
2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
ARMISTICE CAPITAL LLC | 97,000 1.600% |
-149,734 (-60.69%) |
Filing History |
| 2022-02-14 6:43 pm Purchase |
2021-12-31 | 13G | Scopus BioPharma Inc. SCPS |
ARMISTICE CAPITAL LLC | 2,100,000 9.960% |
2,100,000 (New Position) |
Filing History |
| 2022-02-14 6:43 pm Purchase |
2021-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
ARMISTICE CAPITAL LLC | 615,724 9.990% |
615,724 (New Position) |
Filing History |
| 2022-02-14 6:42 pm Purchase |
2021-12-31 | 13G | ReWalk Robotics Ltd. LFWD |
ARMISTICE CAPITAL LLC | 378,686 4.100% |
179,408 (+90.03%) |
Filing History |